Sign In
to Comment, Vote &
Create Storyboards.
 
Global Alliance for TB-Drug Development (TB Alliance) raised hopes of a novel drug regimen to treat both forms of TB--drug sensitive (DS) and multi-drug resistant (MDR)--at the XX International AIDS Conference (AIDS 2014) in Melbourne, offering a new paradigm in TB treatment to treat patients with drugs to which they are sensitive, rather than based on what they are resistant to.
2
0
0


Storyboard
Print


Share this Article



Similar Articles
Comments


Please Sign In to comment


##username##
##datetime##
##comment##
##commentlikeno##Likes
##commentdislikeno##Dislikes